A substantial reduction in PD-1-mAID level in T cells was observed within tumor-infiltrating lymphocytes (TILs) in 5-Ph-IAA-treated mice compared to PBS-treated controls (Fig. 5d, e). This evidence concerns the gene PDCD1 and neoplasm.